Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial

被引：33

作者：

Zhao, Jing ^{[1
]}

Tostivint, Isabelle ^{[2
,3
]}

Xu, Lingdong ^{[1
]}

Huang, Jihan ^{[4
]}

Gambotti, Laetitia ^{[5
]}

Boffa, Jean-Jacques ^{[3
,6
]}

Yang, Min ^{[7
]}

Wang, Ling ^{[8
]}

Sun, Zhuxing ^{[9
]}

Chen, Xiaolan ^{[10
]}

Liou-Schischmanoff, Amelie ^{[3
,11
]}

Baumelou, Alain ^{[2
,3
]}

Ma, Teng ^{[12
]}

Lu, Guoyuan ^{[13
]}

Li, Ling ^{[14
]}

Chen, Dai ^{[15
]}

Pieroni, Laurence ^{[16
]}

Liu, Bingkai ^{[3
]}

Qin, Xiao ^{[1
]}

He, Weiming ^{[1
]}

Wang, Yuejuan ^{[1
]}

Gu, Harvest F. ^{[17
]}

Sun, Wei ^{[1
]}

机构：

[1] Nanjing Univ Chinese Med, Dept Nephrol, Affiliated Hosp, Nanjing, Peoples R China

[2] Sorbonne Univ, Pitie Salpetriere Hosp, Dept Nephrol, Paris, France

[3] Sorbonne Univ, Pitie Salpetriere Hosp, Ctr Integrat Chinese Med, Paris, France

[4] Shanghai Univ Tradit Chinese Med, Ctr Drug Clin Res, Shanghai, Peoples R China

[5] Natl Canc Inst, Dept Clin Res, Boulogne, France

[6] Sorbonne Univ, Hosp Tenon, Dept Nephrol, Paris, France

[7] First Peoples Hosp Changzhou, Dept Nephrol, Changzhou, Peoples R China

[8] First Peoples Hosp Xuzhou, Dept Nephrol, Xuzhou, Peoples R China

[9] Wuxi Peoples Hosp, Dept Nephrol, Wuxi, Jiangsu, Peoples R China

[10] Nantong Univ, Dept Nephrol, Affiliated Hosp, Nantong, Peoples R China

[11] Sorbonne Univ, Dept Pharm, Pitie Salpetriere, Paris, France

[12] Taizhou Hosp Tradit Chinese Med, Dept Nephrol, Taizhou, Peoples R China

[13] Soochow Univ, Dept Nephrol, Affiliated Hosp 1, Suzhou, Peoples R China

[14] Southeast Univ, Zhongda Hosp, Dept Endocrinol, Nanjing, Peoples R China

[15] Changzhou Hosp Tradit Chinese Med, Dept Nephrol, Changzhou, Peoples R China

[16] Sorbonne Univ, Hosp Tenon, Dept Biochem Hormonol, Paris, France

[17] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Nanjing, Peoples R China

来源：

DIABETES CARE | 2022年 / 45卷 / 07期

关键词：

NEPHROPATHY;

D O I：

10.2337/dc22-0607

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：E113 / E115

页数：3

共 50 条

[1] The Efficacy and Safety of Abelmoschus manihot for Reduction of Microalbuminuria in Patients with Type 2 Diabetes and Diabetic Nephropathy-A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Trial
Yin, Jun
Chen, Si
Wei, Li
Jia, Weiping
DIABETES, 2023, 72
[2] Efficacy and Safety of Abelmoschus manihot for Primary Glomerular Disease: A Prospective, Multicenter Randomized Controlled Clinical Trial
Zhang, Li
Li, Ping
Xing, Chang-ying
Zhao, Jiu-yang
He, Ya-ni
Wang, Jian-qin
Wu, Xiong-fei
Liu, Zhang-suo
Zhang, Ai-ping
Lin, Hong-li
Ding, Xiao-qiang
Yin, Ai-ping
Yuan, Fa-huan
Fu, Ping
Hao, Li
Miao, Li-ning
Xie, Ru-juan
Wang, Rong
Zhou, Chun-hua
Guan, Guang-ju
Hu, Zhao
Lin, Shan
Chang, Ming
Zhang, Miao
He, Li-qun
Mei, Chang-lin
Wang, Li
Chen, Xiangmei
AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 64 (01) : 57 - 65
[3] Clinical efficacy and safety of okra (Abelmoschus esculentus (L.) Moench) in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial
Mahdi Tavakolizadeh
Saeid Peyrovi
Hussein Ghasemi-Moghaddam
Ali Bahadori
Zeynab Mohkami
Mahtab Sotoudeh
Mojtaba Ziaee
Acta Diabetologica, 2023, 60 : 1685 - 1695
[4] Efficacy and Safety of Mulberry Twig Alkaloids Tablet for the Treatment of Type 2 Diabetes: A Multicenter, Randomized, Double-Blind, Double-Dummy, and Parallel Controlled Clinical Trial
Qu, Ling
Liang, Xiaochun
Tian, Guoqing
Zhang, Gaili
Wu, Qunli
Huang, Xiumei
Cui, Yazhong
Liu, Yuling
Shen, Zhufang
Xiao, Changqing
Qin, Yingfen
Miao, Heng
Zhang, Yongyan
Li, Ziling
Ye, Shandong
Zhang, Xuezhi
Yang, Jing
Cao, Guiwen
Li, Yi
Yang, Gangyi
Hu, Ji
Wang, Xiaoyue
Li, Zhengfang
Li, Yukun
Zhang, Xiuzhen
Zhang, Guangde
Chen, Li
Hua, Wenjin
Yu, Ming
Lu, Chunyan
Zhang, Xiaomei
Jiang, Hong
DIABETES CARE, 2021, 44 (06) : 1324 - 1333
[5] Efficacy of folic acid and enalapril combined therapy on reduction of blood pressure and plasma glucose: A multicenter, randomized, double-blind, parallel-controlled, clinical trial
Mao, Guangyun
Hong, Xiumei
Xing, Houxun
Liu, Ping
Liu, Haipeng
Yu, Yunxian
Zhang, Shanchun
Jiang, Shanqun
Wang, Xiaobin
Xu, Xiping
NUTRITION, 2008, 24 (11-12) : 1088 - 1096
[6] Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial
Sattarinezhad, A.
Roozbeh, J.
Yeganeh, B. Shirazi
Omrani, G. R.
Shams, M.
DIABETES & METABOLISM, 2019, 45 (01) : 53 - 59
[7] Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial
Rui Wu
Fan Wei
Lianlian Qu
Litao Bai
Jun Li
Fei Li
Weitian Yan
Qiuhong Wang
Junping Wei
Trials, 21
[8] Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial
Wu, Rui
Wei, Fan
Qu, Lianlian
Bai, Litao
Li, Jun
Li, Fei
Yan, Weitian
Wang, Qiuhong
Wei, Junping
TRIALS, 2020, 21 (01)
[9] Correction to: Clinical efficacy and safety of okra (Abelmoschus esculentus (L.) Moench) in type 2 diabetic patients: a randomized, double‑blind, placebo‑controlled, clinical trial
Mahdi Tavakolizadeh
Saeid Peyrovi
Hussein Ghasemi-Moghaddam
Ali Bahadori
Zeynab Mohkami
Mahtab Sotoudeh
Mojtaba Ziaee
Acta Diabetologica, 2023, 60 : 1697 - 1697
[10] Randomized Double-Blind Clinical Trial Comparaing Efficacy and Safety of Pioglitazone and Metformin in Patients with Type 2 Diabetes
Rokeya, Begum
Parvin, Masuma
Bhowmik, Amrita
Chowdhury, A. K. Azad
DIABETES, 2011, 60 : A618 - A618

← 1 2 3 4 5 →